The International Centre for Antimicrobial Resistance Solutions (ICARS)

📢 Webinar: Moving from Evidence to Policy – Mitigating AMR Across One Health Sectors 📅 21st November 2024 ⏰ 14:00 CET Antimicrobial resistance (#AMR) is a global health challenge that spans human, animal, and environmental health sectors. Join ICARS in this #WAAW webinar to explore how intervention and implementation research can drive policy change in AMR. This session will cover:   ◾ Context-specific evidence – Why it’s crucial to inform AMR policy decisions 📌   ◾ Bridging the evidence-policy gap – How the ICARS model supports actionable research 🔍   ◾ Real-world examples – Insights from ICARS-supported projects in Benin, Georgia, and Kosovo 🌍   ◾ Key takeaways – Practical lessons on transforming evidence into impactful policy 💡 Don’t miss this chance to connect, ask questions, and learn how to close the evidence-to-policy gap in AMR. 👉 Register today: https://bit.ly/4hut4vk Victorien DOUGNON Marika Tsereteli Lul Raka Sujith J Chandy Rodolphe Mader #WorldAMRWeek #OneHealth #WAAW2024 

⏰ Less than two weeks left to apply!

📚 Today's #MondayRead highlights how infection prevention and control (IPC) is key to addressing antimicrobial resistance (#AMR). This is especially important in LMICs, where strong IPC can transform resistance management with limited resources.   🏥 A decade-long study (2013-2022) at a large Dutch teaching hospital reveals valuable insights into managing extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), a major challenge due to its antibiotic resistance.    Key Takeaways: ▪️ Average ESBL-E prevalence over 10 years was 4.6%, with annual rates fluctuating between 2.1% and 6.6%. 📉 ▪️ Declining trend: A consistent decrease averaging 5.5% per year, with especially low levels in 2016 and 2020. ⏳ ▪️ Nosocomial transmission: Detected in only 5.9% of cases, with no transmissions in 2020, possibly linked to COVID-19 precautions. 🦠 ▪️ Continued decline: Even post-pandemic, 2021 and 2022 saw low prevalence, hinting at broader infection control successes. 🛡️ 💡 Why it matters: Ongoing surveillance and targeted infection control strategies are crucial to sustaining these gains and preventing antibiotic resistance in hospital settings.   Read more ➡️ https://bit.ly/4fvWMyn Amphia Ziekenhuis Karlijn Houkes, Veronica Weterings, Wouter van den Bijllaardt, M. A.G.M. Tinga, P. G.H. Mulder, Jan Kluytmans, M. M.L. van Rijen, Jaco J. Verweij, Jean-Luc Murk & Joep Stohr 

📢 Upcoming Webinar 📢 In anticipation of #WAAW2024, ICARS invites you to join a webinar on: "Moving from Evidence to Policy: Mitigating AMR across One Health using Intervention and Implementation Research" 🗓 Date: November 21, 2024 🕑 Time: 2:00 PM CET This session will delve into how intervention and implementation research can drive effective, evidence-based policies to address antimicrobial resistance (#AMR) across human, animal, and environmental health sectors. 🔗 Register ➡️ https://bit.ly/4hut4vk #OneHealth #WAAW Rodolphe Mader, Sujith J Chandy, Victorien DOUGNON, Marika Tsereteli, Lul Raka

🌍 What an honour to participate in the workshop on “Strengthening evidence, research, and action to address equity dimensions of antimicrobial resistance”! On Monday, I had the privilege of joining a panel on “Gaps and opportunities to strengthen generation and uptake of evidence and research on equity dimensions of AMR.” The following day we had great discussions on priority areas for addressing these critical equity dimensions within AMR. A heartfelt thank you to Victoria Saint and German Alliance for Global Health Research (GLOHRA) for hosting us and creating such an engaging space for exchange. We were truly honoured to receive encouraging recorded messages from Tedros Adhanom Ghebreyesus and Dame Sally Davies encouraging us to continue action on AMR, gender, and equity. Looking forward to applying these insights and advancing equity and gender in AMR research and action. #AMR #Gender #Equity #GlobalHealth The International Centre for Antimicrobial Resistance Solutions (ICARS)

📚 Today's #MondayRead dives into the critical issue of antimicrobial resistance (#AMR) in livestock and its far-reaching consequences.   🌍 While the economic impact of antimicrobial use (AMU) remains unclear, understanding this burden is vital for both animal health and public welfare.   📊 A new conceptual framework using the Global Burden of Animal Diseases (GBADs) approach aims to clarify these challenges by identifying key data needs and pathways for assessing AMR's impact.   💡 Improved data collection on health expenditures and morbidity can guide effective interventions and policy development.   Read more ➡️ https://bit.ly/40iaWPr   #OneHealth Sara B. João Afonso Christina Fastl Ben Huntington MRCVS PMP Jonathan Rushton University of Liverpool Global Burden of Animal Diseases Sciensano

👏 G7 Health Ministers express support for the work of ICARS in their latest joint declaration.   🌎 Earlier this month, G7 Health Ministers met in Italy to discuss global challenges, including interconnected security, demographic, socio-economic and political issues, all of which are exacerbated by climate change.   📰 The meeting marked the adoption of a joint declaration, which amongst other themes, emphasised how the health of humans, animals, plants and ecosystems are interconnected and supported the implementation of a One Health Approach.   ✅ In a section focused on antimicrobial resistance (#AMR), the declaration explicitly outlines support for the work of ICARS, as well as highlighting the role of infection, prevention and control (IPC) measures, vaccination programmes and #WASH initiatives in reducing the burden of infectious diseases.   Read more ➡  https://lnkd.in/e2PXzysy

📚 Today's #MondayRead is a report from the World Health Organization offering a detailed analysis of the role #vaccines play in reducing antimicrobial resistance (#AMR) and antibiotic use. It examines 44 vaccines targeting 24 pathogens, highlighting how vaccines can: 🔹 Reduce reliance on antibiotics 🔹 Prevent the spread of resistant strains 🔹 Lower economic costs associated with AMR 📊 By modelling potential outcomes, the report emphasises vaccines as a key component of AMR mitigation strategies at both national and global levels. Read more ➡️ https://bit.ly/3NyVMgV Yukiko Nakatani Jeremy Farrar Bruce Aylward Mateusz Hasso-Agopsowicz Isabel Frost Naomi Fuller Kate O'Brien Johan Vekemans Birgitte Giersing, PhD martin friede Eve Wool Mohsen Naghavi Herman GOOSSENS Ann Versporten Ramanan Laxminarayan Chirag Kumar Alisa Hamilton Virginia (Ginny) Pitzer Joseph Lewnard Han Fu Nimalan Arinaminpathy Nicholas Davies Nichola Naylor Mark Jit Kaja Abbas Chaelin Kim Nidhee Jadeja William Hausdorff Gurdip Singh Mann Ali Ruth Michael DiStefano Sanjana Ravi, PhD, MPH Maria Merritt Linda Waldman Dr Violet Barasa Marianne H. Yixuan Ma Gisela Aguilar Julie Robotham Bill & Melinda Gates Foundation Wellcome Trust London School of Hygiene and Tropical Medicine, U. of London

📅 ICARS recently participated in the Nordic–African Women’s Health Forum, which focused on improving health outcomes for women and children. 🤝 Ambassadors from Uganda (Amb. Margaret Otteskov), Kenya (Amb. Angeline Musili, MBS), Rwanda (Dr. Diane Gashumba), Zimbabwe (Amb. Priscila Misihairabwi), and Ghana (Amb. Sylvia Annoh) shared perspectives on joint efforts to combat cancer, enhance vaccination programs, improve maternal and child health, and address key health challenges. The discussions underscored the importance of collaboration in advancing women’s health across the continent. 💡 ICARS' Senior Science Advisor, Erica Westwood, presented on the intersections of Antimicrobial Resistance (#AMR), gender, and equity in Low- and Middle-Income Countries (#LMICs). She highlighted how gender inequalities can limit access to healthcare and emphasized that women are disproportionately affected by drug-resistant infections. 🎤 Other speakers included: Ulla Elisabeth Muller (she/her/hers), Director, UNFPA Nordic Office Kelle Moley, VP, Ferring Pharmaceuticals Dr. Hauqing Li, CEO & Founder, Gynius Plus AB Florence Christensen, CEO & Founder, Connecting Nordic businesses to African markets 🙏 ICARS thanks the organizers, including Women African Ambassadors in Sweden, Ferring Pharmaceuticals, United Nations Population Fund (UNFPA), and other partners for facilitating this important event. Chantal Dusaidi Theresa Hogenhaug Jacqueline N. Ndlovu Read more ➡️ https://bit.ly/4f7OJrn

Join The International Centre for Antimicrobial Resistance Solutions (ICARS) and FAO for a workshop on sustainable AMR mitigation across One Health sectors at the One Sustainable Health by All Conference! 📅 Date: 26 October 2024 🕒 Time: 14:00-15:15 GMT | 16:00-17:15 CEST 📍 Location: Online & In-person (Dakar, Senegal) Workshop focus: 🔹 Why a #OneHealth, multi-stakeholder approach is crucial in mitigation interventions for addressing #AMR 🔹 The state of AMR in Africa: National Action Plans & current gaps 🔹 ICARS model: Collaborative interventions for AMR action plans 🔹 Case studies: ▪️ Ghana: FAO Farmer Field School ▪️ Senegal: The Thiellal Project by Agronomes et Vétérinaires Sans Frontières (VSF-CICDA) 🔹 Interactive discussion: Engage with experts and peers on the best approaches for sustainable AMR mitigation. 🔗 Register ➡️ https://lnkd.in/euJ-QCXk (further details about the workshop will be provided after registration.) One Sustainable Health for All Foundation Galien Africa ENDA Santé Theresa Hogenhaug Rodolphe Mader #OSHbyAll